Nacuity Pharmaceuticals Announces Positive Data from Clinical Trial Evaluating NPI-001 to Treat Retinitis Pigmentosa Associated with Usher Syndrome
September 11, 2025 09:00 ET | Source: Nacuity Pharmaceuticals, Inc. NPI-001 shows…
Athira Pharma Announces Reverse Stock Split
BOTHELL, Wash., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (“Athira”…
Aptitude Test Prep 2025 | ACCUPLACER Practice Test, ATI TEAS Practice Test, SHL, Saville, Watson Glaser, Numerical Reasoning Now Offered by PrepAcademy.org
New York City, NY, Sept. 10, 2025 (GLOBE NEWSWIRE) -- PrepAcademy.org, a…
PrimeEnergy Resources Corporation Recognized Nationally and Locally for Outstanding Performance
Correction to Press Release Issued September 9, 2025, to clarify that At…
NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimers Disease Program
The $2.5 Million in NIH STTR Phase 2 Grant allows NanoNewron to…
KFSHRC Conducts 48% of Clinical Trials in Saudi Arabia During the First Half of 2025
RIYADH, Saudi Arabia, Sept. 10, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist…
Aeluma Announces Fourth Quarter and Full Fiscal Year 2025 Financial Results
Momentum Building with New Contracts, Record Revenue, and Growing Interest Across Multiple…
AppFolio Ignites the Next Era of Real Estate at FUTURE 2025
SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- AppFolio (NASDAQ:APPF), the technology…
Chiesi Global Rare Diseases Highlights Continued Commitment to Rare Disease Community at the International Congress of Inborn Errors of Metabolism (ICIEM) 2025
September 09, 2025 11:00 ET | Source: Chiesi Global Rare Diseases Results…
KFSHRC Deputy CEO at C3 Davos of Healthcare Summit: AI Will Support, Not Replace, Healthcare Workers
NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Artificial intelligence is ready…